|
Quotes & Info
|
| IMMR > SEC Filings for IMMR > Form 10-Q on 6-May-2009 | All Recent SEC Filings |
6-May-2009
Quarterly Report
of future events, or circumstances, are forward-looking statements. Actual
results could differ materially from those projected in the forward-looking
statements as a result of a number of factors, including those set forth below
in Management's Discussion and Analysis of Financial Condition and Results of
Operations and Risk Factors, those described elsewhere in this report, and those
described in our other reports filed with the SEC. We caution you not to place
undue reliance on these forward-looking statements, which speak only as of the
date of this report, and we undertake no obligation to update these
forward-looking statements after the filing of this report. You are urged to
review carefully and consider our various disclosures in this report and in our
other reports publicly disclosed or filed with the SEC that attempt to advise
you of the risks and factors that may affect our business.
OVERVIEW
We are a leading provider of haptic technologies that allow people to use
their sense of touch more fully when operating a wide variety of digital
devices. To achieve this heightened interactivity, we develop and manufacture or
license a wide range of hardware and software technologies and products. While
we believe that our technologies are broadly applicable, we are currently
focusing our marketing and business development activities on the following
target application areas: automotive, consumer electronics, entertainment,
gaming, and commercial and industrial controls; medical simulation; and mobile
communications. We manage these application areas under two operating and
reportable segments: 1) Touch and 2) Medical.
In some markets, such as video console gaming, mobile phones, and automotive
controls, we license our technologies to manufacturers who use them in products
sold under their own brand names. In other markets, such as medical simulation
we sell products manufactured under our own brand name through direct sales to
end users, distributors, OEMs, or value-added resellers. From time to time, we
also engage in development projects for third parties. In the three months ended
March 31, 2009, the Company divested its 3D product line which was part of its
Touch segment. It ceased operations of the 3D product line and sold its
CyberGlove and SoftMouse 3D positioning device product families. The Company has
abandoned all other 3D operations.
Our objective is to drive adoption of our touch technologies across markets
and applications to improve the user experience with digital devices and
systems. We and our wholly owned subsidiaries hold over 700 issued or pending
patents in the U.S. and other countries, covering various aspects of hardware
and software technologies.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
Our discussion and analysis of our financial condition and results of
operations are based upon our condensed consolidated financial statements, which
have been prepared in accordance with GAAP. The preparation of these condensed
consolidated financial statements requires management to make estimates and
assumptions that affect the reported amounts of assets, liabilities, revenues,
expenses, and related disclosure of contingent assets and liabilities. On an
ongoing basis, we evaluate our estimates and assumptions, including those
related to revenue recognition, stock-based compensation, bad debts, inventory
reserves, short-term investments, warranty obligations, patents and intangible
assets, contingencies, and litigation. We base our estimates and assumptions on
historical experience and on various other factors that we believe to be
reasonable under the circumstances, the results of which form the basis for
making judgments about the carrying values of assets and liabilities that are
not readily apparent from other sources. Actual results may differ from these
estimates and assumptions.
We believe the following are our most critical accounting policies as they
require our significant judgments and estimates in the preparation of our
condensed consolidated financial statements:
Revenue Recognition
We recognize revenues in accordance with applicable accounting standards,
including SAB No. 104, EITF No. 00-21, SOP No. 81-1 and SOP No. 97-2. Revenue is
recognized when persuasive evidence of an arrangement exists, delivery has
occurred or service has been rendered, the fee is fixed and determinable,
and collectability is probable. We derive our revenues from three principal
sources: royalty and license fees, product sales, and development contracts.
Royalty and license revenue - We recognize royalty and license revenue based
on royalty reports or related information received from the licensee as well as
time-based licenses of our intellectual property portfolio. Up-front payments
under license agreements are deferred and recognized as revenue either based on
the royalty reports received or amortized over the license period depending on
the nature of the agreement. Advance payments under license agreements that also
require us to provide future services to the licensee are generally deferred and
recognized over the service period when VSOE related to the value of the
services does not exist. These services are not essential to the functionality
of the license agreement.
We generally recognize revenue from our licensees under one or a combination
of the following license models:
License revenue model Revenue recognition
Perpetual license of intellectual Based on royalty reports received
property portfolio based on per unit from licensees. No further
royalties, no services contracted. obligations to licensee exist.
Time-based license of intellectual Based on straight-line amortization
property portfolio with up-front of annual minimum/up-front payment
payments and/or annual minimum recognized over contract period or
royalty requirements, no services annual minimum period.
contracted. Licensees have certain
rights to updates to the
intellectual property portfolio
during the contract period.
Perpetual license of intellectual Based on proportional performance
property portfolio or technology method over the service period or
license along with contract for completed performance method.
development work.
License of software or technology, Up-front revenue recognition based
no modification necessary, no on SOP No. 97-2 criteria or SAB No.
services contracted. 104, as applicable.
|
Individual contracts may have characteristics that do not fall within a
specific license model or may have characteristics of a combination of license
models. Under those circumstances, we recognize revenue in accordance with SAB
No. 104, EITF No. 00-21, SOP No. 81-1, and SOP No. 97-2, as amended, to guide
the accounting treatment for each individual contract. See also the discussions
regarding "Multiple element arrangements" below. If the information received
from our licensees regarding royalties is incorrect or inaccurate, our revenues
in future periods may be adversely affected. To date, none of the information we
have received from our licensees has caused any material reduction in future
period revenues.
Product sales - We recognize revenues from product sales when the product is
shipped, provided the other revenue recognition criteria are met, including that
collection is determined to be probable and no significant obligation remains.
We sell our products with warranties ranging from three to sixty months. We
record the estimated warranty costs during the quarter the revenue is
recognized. Historically, warranty-related costs and related accruals have not
been significant. We offer a general right of return on the MicroScribe product
line for 14 days after purchase. We recognize revenue at the time of shipment of
a
MicroScribe digitizer and provide an accrual for potential returns based on
historical experience. We offer no other general right of return on our
products.
Development contracts and other revenue - Development contracts and other
revenue is comprised of professional services (consulting services and/or
development contracts), customer support, and extended warranty contracts.
Development contract revenues are recognized under the proportional performance
accounting method based on physical completion of the work to be performed or
completed performance method. Losses on contracts are recognized when
determined. Revisions in estimates are reflected in the period in which the
conditions become known. Customer support and extended warranty contract revenue
is recognized ratably over the contractual period.
Multiple element arrangements - We enter into revenue arrangements in which
the customer purchases a combination of patent, technology, and/or software
licenses, products, professional services, support, and extended warranties
(multiple element arrangements). When VSOE of fair value exists for all
elements, we allocate revenue to each element based on the relative fair value
of each of the elements. If vendor specific objective evidence or other
objective evidence of fair value does not exist, the revenue is generally
recorded over the term of the contract.
Our revenue recognition policies are significant because our revenues are a
key component of our results of operations. In addition, our revenue recognition
determines the timing of certain expenses, such as commissions and royalties.
Revenue results are difficult to predict, and any shortfall in revenue or delay
in recognizing revenue could cause our operating results to vary significantly
from quarter to quarter and could result in greater or future operating losses.
Stock-based Compensation
We account for stock-based compensation in accordance with SFAS No. 123R. We
accounted for stock-based compensation using the modified-prospective method,
under which prior periods are not revised for comparative purposes. Under the
fair value recognition provisions of this statement, stock-based compensation
cost is measured at the grant date based on the fair value of the award and is
recognized as expense on a straight-line basis over the requisite service
period, which is the vesting period.
Valuation and amortization method - We use the Black-Scholes model,
single-option approach to determine the fair value of stock options, and ESPP
shares. All share-based payment awards are amortized on a straight-line basis
over the requisite service periods of the awards, which are generally the
vesting periods. The determination of the fair value of stock-based payment
awards on the date of grant using an option-pricing model is affected by our
stock price as well as assumptions regarding a number of complex and subjective
variables. These variables include actual and projected employee stock option
exercise behaviors that impact the expected term and forfeiture rates, our
expected stock price volatility over the term of the awards, risk-free interest
rate, and expected dividends.
Expected term - We estimate the expected term of options granted by
calculating the average term from our historical stock option exercise
experience. We used the simplified method as prescribed by SAB No. 110 for
options granted prior to January 1, 2008.
Expected volatility - We estimate the volatility of our common stock taking
into consideration our historical stock price movement and our expected future
stock price trends based on known or anticipated events.
Risk-free interest rate - We base the risk-free interest rate that we use in
the option pricing model on U.S. Treasury zero-coupon issues with remaining
terms similar to the expected term on the options.
Expected dividend - We do not anticipate paying any cash dividends in the
foreseeable future and therefore use an expected dividend yield of zero in the
option pricing model.
Forfeitures - We are required to estimate future forfeitures at the time of
grant and revise those estimates in subsequent periods if actual forfeitures
differ from those estimates. We record stock-based compensation expense only for
those awards that are expected to vest. We estimate our forfeiture rate based on
anticipated future trends in pre-vesting options and awards forfeitures and
recent historical data.
If factors change and we employ different assumptions for estimating
stock-based compensation expense in future periods, or if we decide to use a
different valuation model, the future periods may differ significantly from what
we have recorded in the current period and could materially affect our operating
results.
The Black-Scholes model was developed for use in estimating the fair value of
traded options that have no vesting restrictions and are fully transferable,
characteristics not present in our option grants and ESPP shares. Existing
valuation models, including the Black-Scholes and lattice binomial models, may
not provide reliable measures of the fair values of our stock-based
compensation. Consequently, there is a risk that our estimates of the fair
values of our stock-based compensation awards on the grant dates may bear little
resemblance to the actual values realized upon the exercise, expiration, early
termination, or forfeiture of those stock-based payments in the future. Certain
stock-based payments, such as employee stock options, may expire and be
worthless or otherwise result in zero intrinsic value as compared to the fair
values originally estimated on the grant date and reported in our financial
statements. Alternatively, value may be realized from these instruments that are
significantly higher than the fair values originally estimated on the grant date
and reported in our financial statements. There currently is no market-based
mechanism or other practical application to verify the reliability and accuracy
of the estimates stemming from these valuation models, nor is there a means to
compare and adjust the estimates to actual values.
See Note 8 to the condensed consolidated financial statements for further
information regarding the SFAS No. 123R disclosures.
Accounting for Income Taxes
We use the asset and liability method of accounting for income taxes. Under
this method, income tax expense is recognized for the amount of taxes payable or
refundable for the current year. In addition, deferred tax assets and
liabilities are recognized for the expected future tax consequences of temporary
differences between the financial reporting and tax bases of assets and
liabilities, and for operating losses and tax credit carryforwards. Valuation
allowances are established when necessary to reduce deferred tax assets to the
amount expected to be realized and are reversed at such time that realization is
believed to be more likely than not. Management must make assumptions,
judgments, and estimates to determine our current provision for income taxes and
also our deferred tax assets and liabilities and any valuation allowance to be
recorded against a deferred tax asset.
Our judgments, assumptions, and estimates relative to the current provision
for income tax take into account current tax laws, our interpretation of current
tax laws, and possible outcomes of current and future audits conducted by
foreign and domestic tax authorities. We have established reserves for income
taxes to address potential exposures involving tax positions that could be
challenged by tax authorities. Although we believe our judgments, assumptions,
and estimates are reasonable, changes in tax laws or our interpretation of tax
laws and any future tax audits could significantly impact the amounts provided
for income taxes in our condensed consolidated financial statements.
Our assumptions, judgments, and estimates relative to the value of a deferred
tax asset take into account predictions of the amount and category of future
taxable income, such as income from operations or capital gains income. Actual
operating results and the underlying amount and category of income in future
years could render inaccurate our current assumptions, judgments, and estimates
of recoverable net deferred taxes. Any of the assumptions, judgments, and
estimates mentioned above could cause our actual income tax obligations to
differ from our estimates, thus materially impacting our financial position and
results of operations.
Short-term Investments
Our short-term investments consist primarily of highly liquid commercial
paper and government agency securities purchased with an original or remaining
maturity of greater than 90 days on the date of purchase. We classify all debt
securities with readily determinable market values as "available-for-sale" in
accordance with SFAS No. 115, "Accounting for Certain Investments in Debt and
Equity Securities." Even though the stated maturity dates of these debt
securities may be one year or more beyond the balance sheet date, we have
classified all debt securities as short-term investments in accordance with
Accounting
Research Bulletin No. 43, Chapter 3A, "Working Capital-Current Assets and
Current Liabilities," as they are reasonably expected to be realized in cash or
sold within one year. These investments are carried at fair market value with
unrealized gains and losses considered to be temporary in nature reported as a
separate component of other comprehensive income (loss) within stockholders'
equity.
We follow the guidance provided by FSP 115-1/124-1 and EITF No. 03-01 "The
Meaning of Other-Than-Temporary Impairment and Its Application to Certain
Investments" to assess whether our investments with unrealized loss positions
are other than temporarily impaired. Realized gains and losses and declines in
value judged to be other than temporary are determined based on the specific
identification method and are reported in the condensed consolidated statement
of operations. Factors considered in determining whether a loss is temporary
include the length of time and extent to which fair value has been less than the
cost basis, the financial condition and near-term prospects of the investee, and
our intent and ability to hold the investment for a period of time sufficient to
allow for any anticipated recovery in market value.
Effective January 1, 2008, we adopted the provisions of SFAS No. 157, which
defines fair value, establishes a framework for measuring fair value, and
expands disclosures about fair value measurements required under other
accounting pronouncements. SFAS No. 157 clarifies that fair value is an exit
price, representing the amount that would be received to sell an asset or paid
to transfer a liability in an orderly transaction between market participants.
SFAS No. 157 also requires that a fair value measurement reflect the assumptions
market participants would use in pricing an asset or liability based on the best
information available. Assumptions include the risks inherent in a particular
valuation technique (such as a pricing model) and/or the risks inherent in the
inputs to the model.
SFAS No. 157 establishes a fair value hierarchy that prioritizes the inputs
to valuation techniques used to measure fair value. The hierarchy gives the
highest priority to unadjusted quoted prices in active markets for identical
assets or liabilities (level 1 measurements) and the lowest priority to
unobservable inputs (level 3 measurements). The three levels of the fair value
hierarchy under SFAS No. 157 are described below:
Level 1: Unadjusted quoted prices in active markets that are accessible at
the measurement date for identical unrestricted assets or liabilities;
Level 2: Quoted prices in markets that are less active or financial
instruments for which all significant inputs are observable, either directly or
indirectly;
Level 3: Prices or valuations that require inputs that are both significant
to the fair value measurement and unobservable.
A financial instrument's level within the fair value hierarchy is based on
the lowest level of any input that is significant to the fair value measurement.
In February 2008, the Financial FASB issued FSP No. 157-2 that delays the
effective date of SFAS No. 157 for nonfinancial assets and nonfinancial
liabilities, except for items that are recognized or disclosed at fair value in
the financial statements on a recurring basis (at least annually) until fiscal
years beginning after November 15, 2008. The delay is intended to allow the FASB
and constituents additional time to consider the effect of various
implementation issues that have arisen, or that may arise, from the application
of SFAS No. 157. We continue to assess the impact that FSP 157-2 may have on our
consolidated financial position and results of operations. The Company does not
believe that FSP 157-2 will have a material impact on its condensed consolidated
financial statements.
Further information about the application of SFAS No. 157 may be found in
Note 2 to the condensed consolidated financial statements.
Recovery of Accounts Receivable
We maintain allowances for doubtful accounts for estimated losses resulting
from our review and assessment of our customers' ability to make required
payments. If the financial condition of one or more
of our customers were to deteriorate, resulting in an impairment of their
ability to make payments, additional allowances might be required.
Inventory Reserves
We reduce our inventory value for estimated obsolete and slow moving
inventory in an amount equal to the difference between the cost of inventory and
the net realizable value based upon assumptions about future demand and market
conditions. If actual future demand and market conditions are less favorable
than those projected by management, additional inventory write-downs may be
required.
Product Return and Warranty Reserves
We provide for estimated costs of future anticipated product returns and
warranty obligations based on historical experience when related revenues are
recognized, and we defer warranty-related revenue over the related warranty
term.
Intangible Assets
We have acquired patents and other intangible assets. In addition, we
capitalize the external legal and filing fees associated with patents and
trademarks. We assess the recoverability of our intangible assets, and we must
make assumptions regarding estimated future cash flows and other factors to
determine the fair value of the respective assets that affect our consolidated
financial statements. If these estimates or related assumptions change in the
future, we may be required to record impairment charges for these assets. We
amortize our intangible assets related to patents and trademarks, over their
estimated useful lives, generally 10 years. Future changes in the estimated
useful life could affect the amount of future period amortization expense that
we will incur. During the first three months of 2009, we capitalized costs
associated with patents and trademarks of $767,000. Our total amortization
expense for the same period for all intangible assets was $376,000.
Restructuring Costs
In connection with our exit activities, we record restructuring charges for
employee termination costs and other exit-related costs. These charges are
incurred pursuant to formal plans developed by management and accounted for in
accordance with SFAS No. 146, "Accounting for Costs Associated with Exit or
Disposal Activities". The recognition of restructuring charges requires our
management to make judgments and estimates regarding the nature, timing, and
amount of costs associated with the planned exit activity, including move
related costs and the fair value, less selling costs, of property, plant and
equipment to be disposed of. Estimates of future liabilities may change,
requiring us to record additional restructuring charges or reduce the amount of
liabilities already recorded. At the end of each reporting period, we evaluate
the remaining accrued balances to ensure their adequacy, that no excess accruals
are retained, and that the utilization of the provisions are for their intended
purposes in accordance with developed exit plans. In the event circumstances
change and the provision is no longer required, the provision is reversed.
The above listing is not intended to be a comprehensive list of all of our
accounting policies. In many cases, the accounting treatment of a particular
transaction is specifically dictated by GAAP, with no need for management's
judgment in their application. There are also areas in which management's
judgment in selecting any available alternative would not produce a materially
different result.
RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED MARCH 31, 2009 AND 2008
The following discussion and analysis includes the Company's results of
operations from continuing operations for the three months ended March 2009 and
2008. A separate discussion of the 3D product line under discontinued operations
has been presented following our analysis of continuing operations. Accordingly,
the sales, gross profit, sales and marketing expense, and income tax provision
from our discontinued operations have been aggregated and reported as loss from
discontinued operations and are not a component of the aforementioned continuing
operations discussion.
Overview
We achieved a 1% increase in revenues from continuing operations during the
three months ended March 31, 2009 as compared to the three months ended
March 31, 2008. The first three months revenue growth was primarily due to a 9%
increase in royalty and license revenues from increased Touch royalty and
license fees mainly from customers that sell mobile devices. The revenue
increase also included a 3% increase in product sales partially offset by a 44%
decrease in development contract revenues. In conjunction with our plan to move
our medical operating segment to San Jose and other workforce reductions in our
Touch segment, we had restructuring costs relating to workforce reductions of
$646,000. We divested our 3D product line and recorded a gain of $235,000 from
discontinued operations for the three months ended March 31, 2009 as compared to
a gain of $322,000 for the three months ended March 31, 2008. We also had a gain
on sale of discontinued operations of $167,000 for the three months ended
March 31, 2009. Our net loss was $7.5 million for the three months ended
March 31, 2009 compared to a net loss of $2.6 million for the three months ended
March 31, 2008.
With our divestiture of the 3D product line, our move of the medical
operating segment to San Jose, and other restructuring efforts, we hope to
achieve cost reductions in 2009. In 2009, we expect to continue to focus on the
. . .
|
|